The past, present, and future of myeloma staging and risk prognostication
With the emergence of several new staging and risk stratification systems in myeloma, we have explored the evolution of these frameworks-past, present, and future. We examine how staging systems have evolved over time, the strengths of current models, and the limitations that future research can address to further improve prognostication.
Authors
- Ghulam Rehman Mohyuddin (ORCID: https://orcid.org/0000-0001-6464-783X)
- Mehmet Baysal (ORCID: https://orcid.org/0000-0001-7681-4623)
- Gliceida Galarza Fortuna (ORCID: https://orcid.org/0000-0002-1084-953X)
- Jens G. Lohr (ORCID: https://orcid.org/0000-0003-3486-2445)
- Douglas W. Sborov (ORCID: https://orcid.org/0000-0003-4268-2698)
- Amandeep Godara (ORCID: https://orcid.org/0000-0003-1943-4442)
- Brian McClune (ORCID: https://orcid.org/0000-0003-0007-4192)
- Kelley Julian (ORCID: https://orcid.org/0000-0002-2111-2461)
Institutions
- Tekirdağ Namık Kemal University (TR)
- University of Utah (US)
- Huntsman Cancer Institute (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1093/oncolo/oyaf299
- Citations
- 2
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54